| Literature DB >> 34907234 |
Victória Soares Soeiro1,2, Ricardo Silva-Carvalho2, Daniela Martins2, Pier Parpot2,3, Denise Grotto4, Marco Vinicius Chaud5, Francisco Miguel Portela da Gama2, Angela Faustino Jozala6.
Abstract
Nanocomplexes systems made up natural poylymers have pharmacotechnical advantages such as increase of water solubility and a decrease of drugs toxicity. Amphotericin B (AmB) is a drug apply as anti-leishmanial and anti-fungal, however it has low water solubility and high toxicity, limiting its therapeutic application. With this in mind, the present study aimed to produce nanocomplexes composed by alginate (Alg), a natural polymer, with AmB covered by nanocrystals from bacterial cellulose (CNC). For this reason, the nanocomplexes were produced utilizing sodium alginate, amphotericin B in a borate buffer (pH 11.0). The CNC was obtained by enzymatic hydrolysis of the bacterial cellulose. To CNC cover the nanocomplexes 1 ml of the nanocomplexes was added into 1 ml of 0.01% CNC suspension. The results showed an ionic adsorption of the CNC into the Alg-AmB nanocomplexes surface. This phenomena was confirmed by an increase in the particle size and PDI decrease. Besides, nanocomplexes samples covered by CNC showed uniformity. The amorphous inclusion of AmB complex into the polysaccharide chain network in both formulations. AmB in the nanocomplexes was in supper-aggregated form and showed good biocompatibility, being significantly less cytotoxic in vitro against kidney cells and significantly less hemolytic compared to the free-drug. The in vitro toxicity results indicated the Alg-AmB nanocomplexes can be considered a non-toxic alternative to improve the AmB therapeutic effect. All process to obtain nanocomplexes and it coat was conduce without organic solvents, can be considered a green process, and allowed to obtain water soluble particles. Furthermore, CNC covering the nanocomplexes brought additional protection to the system can contribut advancement in the pharmaceutical.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34907234 PMCID: PMC8671405 DOI: 10.1038/s41598-021-03264-1
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Analysis of the size, PDI and zeta potential of Alg-AmB Alg-AmB + CNC).
| CNC | Alg-AmB | Alg-AmB + CNC | |
|---|---|---|---|
| Size (nm) | 41.67 ± 5.55 | 258.87 ± 10.41 | 466.3 ± 17.57 |
| Index of polydispersity | 0.127 ± 0.005 | 0.523 ± 0.073 | 0.420 ± 0.05 |
| Zeta potential (mV) | 7.57 ± 2.26 mV | −62.93 ± 2.02 | −55.75 ± 1.23 |
Figure 1(A) Differential Scanning Calorimetry (DSC). (B) Infrared spectrum by Fourier transform (FTIR). (C) Design Production of Alg-AmB and Alg-AmB + CNC. (D) UV–Vis spectrometry. Note: A – DSC analysis of AmB, Alg, CNC, alginate + AmB (mixture), Alg-AmB and Alg-AmB + CNC. B – FTIR of pure alginate, Alg and Alg-AmB. D – UV–Vis spectrometry of the AmB, Alg-AmB and Alg-AmB + CNC.
Figure 2Percentage of hemolysis after treatment of red blood cells (A) Cytotoxicity of the renal cell line HEK293T (B) with Alg, Alg-AmB, Alg-AmB + CNC, AMBISOME and AmB. Note: A AmB (*) and Alg-AmB (**) were compared to the other groups by the Duncan test (p < 0.05). B – AmB (*) was compared to the other groups by the Duncan test (p < 0.05).
Formulation of alginate (Alg) and alginate-amphotericin B (Alg-AmB) to prepare the nanocomplexes.
| Formulations | Borate buffer pH 11 (mL) | Sodium alginate (mg) | Amphotericin B (mg) |
|---|---|---|---|
| Alg | 9.6 | 120 | – |
| Alg-AmB | 9.6 | 96 | 24 |